LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 62 filers reported holding LEGEND BIOTECH CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,967,788 | -8.2% | 461,036 | -5.7% | 0.59% | -3.3% |
| Q2 2023 | $33,738,896 | +38.7% | 488,757 | -3.1% | 0.61% | +25.4% |
| Q1 2023 | $24,327,954 | -13.1% | 504,520 | -10.0% | 0.49% | -19.0% |
| Q4 2022 | $27,998,980 | -44.9% | 560,877 | -54.9% | 0.60% | -46.7% |
| Q3 2022 | $50,770,000 | -25.3% | 1,244,362 | +0.6% | 1.13% | +20.3% |
| Q2 2022 | $68,006,000 | +6.1% | 1,236,471 | -29.9% | 0.94% | +31.3% |
| Q1 2022 | $64,071,000 | -29.3% | 1,763,090 | -9.3% | 0.72% | -14.7% |
| Q4 2021 | $90,597,000 | -6.7% | 1,943,717 | +1.2% | 0.84% | -10.0% |
| Q3 2021 | $97,068,000 | +21.1% | 1,919,866 | -1.6% | 0.94% | +30.9% |
| Q2 2021 | $80,123,000 | +44.0% | 1,951,845 | +1.8% | 0.72% | +38.3% |
| Q1 2021 | $55,627,000 | +3.1% | 1,916,845 | 0.0% | 0.52% | +3.4% |
| Q4 2020 | $53,978,000 | -13.4% | 1,916,845 | -5.1% | 0.50% | -27.1% |
| Q3 2020 | $62,325,000 | -27.5% | 2,018,956 | 0.0% | 0.69% | -34.5% |
| Q2 2020 | $85,927,000 | – | 2,018,956 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |